Suchergebnisse - "Chamorey, Emmanuel"

PubPharm (9)

1

Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy : DIRECT

enthalten in: Cancer reports (Hoboken, N.J.) | 2022

von Guigay, J. | Chamorey, E. | Lefebvre, G. | +8

2

Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2021

von Culié, D. | Schiappa, R. | Modesto, A. | +29

3

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

enthalten in: Cancer immunology, immunotherapy : CII | 2017

von Lattanzio, L. | Denaro, N. | Vivenza, D. | +9

4

Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab

enthalten in: JAMA dermatology | 2017

von Picard, A. | Pedeutour, F. | Peyrade, F. | +13

CommentIn: JAMA Dermatol. 2017 Apr 1;153(4):253-255. - PMID 28259106

5

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

enthalten in: Cancer immunology immunotherapy | 2017

von Lattanzio, L. | Denaro, N. | Vivenza, D. | +9

6

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

enthalten in: Cancer immunology immunotherapy | 2017

von Lattanzio, L. | Denaro, N. | Vivenza, D. | +9

7

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

enthalten in: Cancer immunology immunotherapy | 2017

von Lattanzio, L. | Denaro, N. | Vivenza, D. | +9

8

Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation : A preclinical study on an orthotopic xenograft model of head and neck cancer

enthalten in: Head & neck | 2017

von Bozec, A. | Ebran, N. | Radosevic-Robin, N. | +6

9

Telomeric repeat-binding factor 2 : a marker for survival and anti-EGFR efficacy in oral carcinoma

enthalten in: Oncotarget | 2016

von Benhamou, Y. | Picco, V. | Raybaud, H. | +8

1
[1]